#AASLD2024 Archives - MediaMedic

Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment

By Mourabit Halima 2025.01.06

Recently, the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. The prestigious event brought together leading experts and scholars in the field…

Expert Interview with Dr. Jun Li: New Insights into Hepatitis B-Related ACLF Research

By Lisa Cui 2025.01.02

Acute-on-Chronic Liver Failure (ACLF) is one of the most severe and life-threatening liver diseases in China and the Asia-Pacific region. This complex condition arises from multiple factors, with host genetic…

AASLD Exclusive Interview with Dr. Grace Lai-Hung Wong: Quantitative HBsAg – A New Perspective in Advancing Hepatitis B Management and Functional Cure

By Peng Longmei 2024.12.27

With significant progress in hepatitis B treatment, particularly in the pursuit of a functional cure, the quantification of hepatitis B surface antigen (HBsAg) has emerged as a critical factor in…

AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

By Lisa Cui 2024.12.26

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise globally, driven by the increasing rates of obesity and metabolic syndrome. Epidemiological studies indicate that by 2019, the…

AASLD Expert Interview丨Dr. Lungen Lu Shares New Advances in MASLD Research

By Peng Longmei 2024.12.24

From November 15 to 19, 2024, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. Hepatology Digest invited…

AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

By Mourabit Halima 2024.12.24

Recently, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At the event, a team led by Dr.…

AASLD 2024丨Dr. Hui Wang’s Team: Serum HBV RNA and HBcrAg as Predictors of Low-Level Viremia in CHB Patients Treated with Nucleos(t)ide Analogs

By Mourabit Halima 2024.12.23

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Dr. Hui Wang’s team from the Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao…

AASLD 2024: Dr. Mingqin Lu’s Team Presents Study on Biomimetic Exosomes Loaded with Iridium Nanozyme for Acute Liver Failure Treatment

By Mourabit Halima 2024.12.17

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, Professor Mingqin Lu’s team from The First Affiliated Hospital of Wenzhou Medical University unveiled their latest…

AASLD 2024丨Dr. Xiaohong Gao: Initiating TDF at Different Gestational Weeks Safely Prevents HBV Mother-to-Child Transmission

By Lisa Cui 2024.12.06

Despite extensive research, there remains no universal consensus on the optimal timing for initiating antiviral therapy during pregnancy to prevent hepatitis B virus (HBV) mother-to-child transmission (MTCT). Divergent recommendations have…

AASLD 2024丨Dr. Hong You and Dr. Aiting Yang ‘s Team Unveils the Critical Role of ECM1-Expressing HSC Subpopulations in Liver Fibrosis Reversal

By El Bachir MOURABIT 2024.12.05

Recent advancements in single-cell transcriptomics have uncovered the significant heterogeneity of hepatic stellate cells (HSCs), highlighting the unique gene expression profiles and functions of different HSC subpopulations. At the 2024…